Inventors list
Assignees list
Classification tree browser
Top 100 Inventors
Top 100 Assignees
38th week of 2016 patent applcation highlights part 9
Patent application number
Title
Published
20160271087
Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases
2016-09-22
20160271088
Compositions and Methods for Treating Chronic Inflammation and Inflammatory Diseases
2016-09-22
20160271089
METHODS AND COMPOSITIONS FOR ORAL DELIVERY OF FTS
2016-09-22
20160271090
FRATAXIN ENHANCER
2016-09-22
20160271091
Alpha-Aminoadipate For Treatment Of Vision Loss And Restoring Sight
2016-09-22
20160271092
TOPICAL PHARMACEUTICAL COMPOSITION OF ACITRETIN
2016-09-22
20160271093
CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
2016-09-22
20160271094
Laquinimod Combination Therapy For Treatment Of Multiple Sclerosis
2016-09-22
20160271095
Therapeutic for Treating Inflammatory Lung Disorders
2016-09-22
20160271096
THERAPEUTIC OXIDATIVE FORMULATIONS AND METHODS OF USE THEREOF
2016-09-22
20160271097
FORMULATION OF OLOPATADINE
2016-09-22
20160271098
TREATMENT OF TINNITUS THROUGH MODULATION OF CHLORIDE CO-TRANSPORTER NKCC1 IN THE AUDITORY SYSTEM
2016-09-22
20160271099
NOVEL COMPOUNDS AND COMPOSITIONS FOR TARGETING CANCER STEM CELLS
2016-09-22
20160271100
METHOD FOR TREATING TUMORS AND RADIOTHERAPY- AND CHEMOTHERAPY-ASSOCIATED COGNITIVE OR EMOTIONAL IMPAIRMENT WITH CANNABINOIDS
2016-09-22
20160271101
Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders
2016-09-22
20160271103
DIETARY SUPPLEMENT CONTAINING ALKALINE ELECTROLYTE BUFFERS
2016-09-22
20160271104
SMALL MOLECULE, INDIRUBIN-3-OXIME, FOR PREVENTION AND TREATMENT OF BONE DISEASE
2016-09-22
20160271105
MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS
2016-09-22
20160271106
TREATMENT OF CANCER
2016-09-22
20160271107
Spirocyclic Cyclohexane Compounds Useful To Treat Substance Dependency
2016-09-22
20160271108
METHODS AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
2016-09-22
20160271109
Peptides For Skin Rejuvenation And Methods Of Using The Same
2016-09-22
20160271110
OXYMETAZOLINE FOR THE TREATMENT OF ANO-RECTAL DISORDERS
2016-09-22
20160271111
Methods for treating hyperuricemia in patients with gout using halofenate or halofenic acid and a second urate-lowering agent
2016-09-22
20160271112
THERAPY FOR CHRONIC IDIOPATHIC URTICARIA, ANAPHYLAXIS AND ANGIOEDEMA
2016-09-22
20160271113
METHODS AND COMPOSITIONS FOR TREATING SEPSIS
2016-09-22
20160271114
Composition for preventing or treating bacterial infectious disease comprising phospholipase D2 inhibitor
2016-09-22
20160271115
IMMUNOSUPPRESIVE TREATMENTS, FORMULATIONS AND METHODS
2016-09-22
20160271116
POLYETHYLENE GLYCOL-CACTUS OLIGOPEPTIDE BONDING RAPAMYCIN DERIVATIVES
2016-09-22
20160271118
PHARMACEUTICAL COMPOSITIONS COMPRISING ANTIBACTERIAL AGENTS
2016-09-22
20160271119
Method of Treating Periodontal Disease by Altering an Epithelial to Mesenchymal Transition
2016-09-22
20160271120
PHARMACEUTICAL COMPOSITION FOR CLEANSING OF THE GASTROINTESTINAL TRACT
2016-09-22
20160271121
ANTIFUNGAL COMBINATION THERAPY
2016-09-22
20160271122
COMBINATIONS OF MEK INHIBITORS AND RAF KINASE INHIBITORS AND USES THEREOF
2016-09-22
20160271123
NOVEL COMPOUNDS AS REARRANGED DURING TRANSFECTION (RET) INHIBITORS
2016-09-22
20160271124
FORMULATIONS CONTAINING NALBUPHINE AND USES THEREOF
2016-09-22
20160271125
SUSTAINED RELEASE OF ANTIINFECTIVES
2016-09-22
20160271126
PHARMACEUTICAL COMPOSITION
2016-09-22
20160271127
CANNABINOID RECEPTOR MODULATORS
2016-09-22
20160271128
COMPOSITION FOR REDUCING NERVOUS SYSTEM INJURY AND METHOD OF MAKING AND USE THEREOF
2016-09-22
20160271129
COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
2016-09-22
20160271130
HEPATITIS B VIRAL ASSEMBLY EFFECTORS
2016-09-22
20160271131
METHODS OF USING DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR TREATMENT OF RESPIRATORY AND GASTROINTESTINAL DISEASES
2016-09-22
20160271132
TREATMENT OF CANCER AND BENIGN PROLIFERATIVE DISORDERS
2016-09-22
20160271133
Methods of Treating Multiple Myeloma and Resistant Cancers
2016-09-22
20160271134
Modulators of Androgen Synthesis
2016-09-22
20160271135
NASAL COMPOSITIONS STIMULATING CILIARY ACTIVITY
2016-09-22
20160271136
Drug Combinations and Uses in Treating a Coughing Condition
2016-09-22
20160271137
INHIBITORS OF LONG AND VERY LONG CHAIN FATTY ACID METABOLISM AS BROAD SPECTRUM ANTI-VIRALS
2016-09-22
20160271138
Combination Therapies for the Treatment of Alzheimer's Disease and Related Disorders
2016-09-22
20160271139
METHOD FOR NON-TOXIC TREATMENT FOR DRUG WITHDRAWAL
2016-09-22
20160271140
COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE
2016-09-22
20160271141
FUSED BENZAZEPINES FOR TREATMENT OF STUTTERING
2016-09-22
20160271142
ISOQUINOLIDINOBENZODIAZEPINES
2016-09-22
20160271143
ESTROGEN RECEPTOR MODULATORS FOR REDUCING BODY WEIGHT
2016-09-22
20160271145
METHOD FOR ENLARGING THE PARTICLE SIZE OF CRYSTALLINE MICROPARTICLES OF ACTIVE SUBSTANCE
2016-09-22
20160271146
PHARMACEUTIC COMPOSITION COMPRISING OF HDAC INHIBITOR AND A STEROID AND THE USE THEREOF
2016-09-22
20160271147
CHITOSAN-BASED MATRICES AND USES THEREOF
2016-09-22
20160271148
CHITOSAN-BASED MATRICES AND USES THEREOF
2016-09-22
20160271149
THERAPEUTIC COMPOUNDS THAT SUPPRESS PROTEIN ARGININE METHYLTRANSFERASE ACTIVITY FOR REDUCING TUMOR CELL PROLIFERATION
2016-09-22
20160271150
METHODS OF PREVENTION OR TREATMENT FOR PATHOLOGIC THROMBOSIS OR INFLAMMATION
2016-09-22
20160271151
HYDROGEL FORMULATION FOR DERMAL AND OCULAR DELIVERY
2016-09-22
20160271152
CELL-FREE TISSUED ENGINEERED VASCULAR GRAFTS
2016-09-22
20160271153
Novel Methods For The Treatment Of Cardiac Arrhythmias
2016-09-22
20160271154
USE OF GINSENOSIDE-RG3 IN PREPARING MEDICINE FOR PREVENTING OR/AND TREATING DEMENTIA AND MEDICINE
2016-09-22
20160271155
Vitamin Formulations
2016-09-22
20160271156
ANTI-CANCER COMPOUNDS AND METHODS FOR TREATING CANCER
2016-09-22
20160271157
BETA-CATENIN
2016-09-22
20160271158
CONCENTRATED NATAMYCIN SUSPENSION FORMULATIONS
2016-09-22
20160271159
Methods and Devices for Treating Conditions Associated with Autonomic Dysfunction
2016-09-22
20160271160
HCV POLYMERASE INHIBITORS
2016-09-22
20160271161
METHOD FOR TREATING HAEMORRHAGE, SHOCK AND BRAIN INJURY
2016-09-22
20160271162
D-ALANINE PHOSPHORAMIDE PRONUCLEOTIDES OF 2'-METHYL 2'-FLURO GUANOSINE NUCLEOSIDE COMPOUNDS FOR THE TREATMENT OF HCV
2016-09-22
20160271163
INHIBITION OF A lncRNA FOR TREATMENT OF MELANOMA
2016-09-22
20160271164
COMPOSITIONS, KITS, AND METHODS TO INDUCE ACQUIRED CYTORESISTANCEUSING STRESS PROTEIN INDUCERS
2016-09-22
20160271165
POLYLNOSINIC-POLYCYTIDYLIC ACID (POLY (I:C)) FORMULATIONS FOR THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS
2016-09-22
20160271166
COMPOSITIONS AND METHODS FOR ENHANCING PHYSIOLOGICAL PERFORMANCE AND RECOVERY TIME
2016-09-22
20160271167
METHOD FOR DETECTION TREATMENT AND PREVENTION OF NEUROLOGICAL DEVELOPMENT DISORDERS
2016-09-22
20160271168
System And Method Of Administering A Pharmaceutical Gas To A Patient
2016-09-22
20160271169
Methods of Using Inhaled Nitric Oxide Gas for Treatment of Acute Respiratory Distress Syndrome in Children
2016-09-22
20160271170
COMPOSITIONS AND METHODS FOR OBTAINING AN IMPROVED LUNG FUNCTION
2016-09-22
20160271171
HAND DISINFECTANT
2016-09-22
20160271172
METHODS FOR TREATING SKIN IRRITATION
2016-09-22
20160271173
METHODS OF TREATING CHRONIC RHINOSINUSITIS
2016-09-22
20160271174
MICROPOROUS ZIRCONIUM SILICATE FOR THE TREATMENT OF HYPERKALEMIA
2016-09-22
20160271175
Metal Complexes and Methods of Treatment
2016-09-22
20160271176
TRACE ELEMENTS
2016-09-22
20160271177
PROCESS FOR BIO SYNTHESIS OF NANO ARSENIC TRIOXIDE AND ITS USE IN TREATMENT OF DISEASES INCLUDING CANCER
2016-09-22
20160271178
NANOPARTICLE-CONTAINING HYDROGELS
2016-09-22
20160271179
METHODS OF PREVENTING PLATELET ALLOIMMUNIZATION AND ALLOIMMUNE PLATELET REFRACTORINESS AND INDUCTION OF TOLERANCE IN TRANSFUSED RECIPIENTS
2016-09-22
20160271180
IL-17 PRODUCTION INHIBITORY COMPOSITION
2016-09-22
20160271181
METHODS AND COMPOSITIONS FOR TREATMENT OF RETINAL DEGENERATION
2016-09-22
20160271182
ISOLATION OF HUMAN NEURAL STEM CELLS FROM AMNIOTIC FLUID OF PATIENTS WITH NEURAL TUBE DEFECTS
2016-09-22
20160271183
DIRECTED CARDIOMYOCYTE DIFFERENTIATION AND VENTRICULAR SPECIFICATION OF STEM CELLS
2016-09-22
20160271184
METHODS OF TREATING INFLAMMATORY COLON DISEASES
2016-09-22
20160271185
METHOD OF PREPARING SOLUTION CONTAINING STEM CELLS
2016-09-22
20160271186
COMPOSITIONS COMPRISING PERIVASCULAR STEM CELLS AND NELL-1 PROTEIN
2016-09-22
20160271187
COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING TISSUE INJURY AND DISEASE
2016-09-22
20160271188
PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND METHODS OF USE THEREOF FOR TREATMENT OF GASTROINTESTINAL DISORDERS
2016-09-22
20160271189
METHODS AND COMPOSITIONS RELATING TO MICROBIAL TREATMENT AND DIAGNOSIS OF SKIN DISORDERS
2016-09-22